abstract |
It is an object of the present invention to provide a radiometal anticadherin antibody highly specific to cancer tissues, a cancer therapeutic drug having high anticancer effect, and high safety. In order to solve the above problems, the radioactive metal labeled anticadherin antibody of the present invention is characterized in that the radioactive metal element is bound to the anticadherin antibody via a metal chelate reagent. |